Real-World Experience of Methotrexate in the Treatment of Skin Diseases: an Italian Delphi Consensus Giovanni DamianiPaolo AmerioPaolo D. M. Pigatto Guidelines Open access 21 May 2023 Pages: 1219 - 1241
Impact and Management of Loss of Eyebrows and Eyelashes Michela StaraceStephano CedirianMatilde Iorizzo Review Open access 15 May 2023 Pages: 1243 - 1253
Topical Isotretinoin (TMB-001) Treatment for 12 Weeks Did Not Result in Clinically Relevant Laboratory Abnormalities in Participants with Congenital Ichthyosis in the Phase 2b CONTROL Study Kalyani MaratheJoyce M. C. TengDédée F. Murrell Original Research Open access 11 May 2023 Pages: 1255 - 1264
Photodynamic Therapy is an Effective Treatment of Facial Pigmented Actinic Keratosis Ewelina MazurAdam Reich Original Research Open access 10 May 2023 Pages: 1265 - 1276
Treatment of Stretch Marks Using a New Formulation Combining Nanofractional Radiofrequency Plus Magnetic Nanofractional Radiofrequency Xiaohong ShuWei HuoXi Wang Original Research Open access 12 May 2023 Pages: 1277 - 1288
Suboptimal Clinical and Quality of Life Outcomes in Patients with Psoriasis Undertreated with Oral Therapies: International Physician and Patient Survey Sydney ThaiSophie BarlowJashin J. Wu Original Research Open access 31 May 2023 Pages: 1289 - 1303
Biologic TNF-α Inhibitors for Stevens–Johnson Syndrome, Toxic Epidermal Necrolysis, and TEN-SJS Overlap: A Study-Level and Patient-Level Meta-Analysis Jiali CaoXuan ZhangJie Fan Original Research Open access 13 May 2023 Pages: 1305 - 1327
Patient and Physician Perceptions of Psoriatic Disease in the United States: Results from the UPLIFT Survey Joseph F. MerolaAlexis OgdieMark Lebwohl Original Research Open access 15 May 2023 Pages: 1329 - 1346
Drug Survival of Tumor Necrosis Factor-Alpha Inhibitors and Switched Subsequent Biologic Agents in Patients with Psoriasis: A Retrospective Study Megumi KishimotoMayumi KomineMamitaro Ohtsuki Original Research Open access 19 May 2023 Pages: 1347 - 1360
The Needs of Patients with Psoriasis and Benefits of Apremilast in French Clinical Practice: Results from the Observational REALIZE Study Denis JullienMarie-Aleth RichardAnne Bouloc Original Research Open access 19 May 2023 Pages: 1361 - 1376
InflammamiR-146a and -155 Plasma Levels are Associated with Clinical Efficacy of Risankizumab Treatment in Psoriatic Patients: Pilot Study Federico DiotalleviGiulia MatacchioneAnnamaria Offidani Brief Report Open access 17 May 2023 Pages: 1377 - 1387
Publisher Correction: Long-Term Health-Related Quality of Life in Patients with Plaque Psoriasis Treated with Certolizumab Pegol: Three-Year Results from Two Randomised Phase 3 Studies (CIMPASI-1 and CIMPASI-2) Paolo GisondiAlice B. GottliebMark Lebwohl Publisher Correction Open access 30 May 2023 Pages: 1389 - 1390